Stockscreener 앱 받기
250.19
0.28%
0.5716
Labcorp Holdings Inc 주식(LH)의 최신 뉴스
Hanging in the Balance: Supreme Court Declines to Decide the Uninjured Class Member Question in Labcorp v. Davis - JD Supra
Employees seek leadership development—but access gaps may hold them back, new report finds - GlobeNewswire Inc.
Labcorp Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72 - simplywall.st
HSBC Downgrades Labcorp to Hold From Buy, $260 Price Target - MarketScreener
Labcorp Declares Quarterly Dividend, Enhancing Shareholder Value - TipRanks
Labcorp Declares Quarterly Dividend - PR Newswire
Privia Health appoints former Labcorp CTO to board of directors - Investing.com
Healthcare Tech Expert Joins Privia Health Board: Former Labcorp CTO to Drive Digital Innovation - Stock Titan
What Makes Labcorp (LH) a New Buy Stock - Nasdaq
Labcorp Holdings stock hits 52-week high at $264.04 By Investing.com - Investing.com Australia
Labcorp Holdings stock hits 52-week high at $264.04 - Investing.com
Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low (NYSE:LH) - Seeking Alpha
LabCorp's Credit Facility Overhaul: A Playbook for Sustained Growth in Diagnostics - AInvest
Labcorp Holdings Secures $1 Billion Credit Facility - TipRanks
Labcorp to Announce Second Quarter Financial Results on July 24, 2025 - GuruFocus
Labcorp Holdings to Announce Q2 2025 Financial Results - TipRanks
Labcorp Holdings (LH) Receives Price Target Increase from Barcla - GuruFocus
Barclays Adjusts Labcorp (LH) Price Target to $275 Amid Q2 Outlook | LH Stock News - GuruFocus
Fortrea Holdings Inc. Stockholders Should Contact Robbins - GlobeNewswire
Is Labcorp Holdings Stock Outperforming the Dow? - MSN
Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge? - Nasdaq
Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care - marketscreener.com
Labcorp Revolutionizes Healthcare Testing with New 1000+ Biomarker Platform for Holistic Medicine - Stock Titan
Baird Adjusts Price Target on Labcorp Holdings to $290 From $268, Maintains Outperform Rating - MarketScreener
Morgan Stanley Hikes Labcorp (LH) Holdings Price Target to $283 Affirms ‘Overweight’ Rating - Yahoo Finance
Labcorp Shares Soar 1.11% on Strong Q1 Earnings - AInvest
FTRE INVESTOR DEADLINE: Robbins Geller Rudman & Dowd Announces that Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE - FinancialContent
Kaplan Fox Reminds Fortrea Holdings Inc. (FTRE) Investors of a Securities Class Action Deadline on August 1, 2025 - FinancialContent
Class Standing Issues Still Murky After Justices Punt LabCorp - Law360
Labcorp (LH) Gains Exclusive 3D Liver Models from Predictive Onc - GuruFocus
Labcorp director Kerrii Anderson sells shares worth $130,000 By Investing.com - Investing.com Canada
Labcorp director Kerrii Anderson sells shares worth $130,000 - Investing.com Australia
Predictive Oncology Develops 3D Liver Toxicity Models for Labcorp - marketscreener.com
Predictive Oncology Inc. Develops Functional 3D Organoid Models Exclusively for Labcorp - MarketScreener
Kaplan Fox Encourages Investors of Fortrea Holdings Inc. (FTRE) to Contact the Firm Before Lead Plaintiff Deadline on August 1, 2025 - The Globe and Mail
Investing in Labcorp Holdings (NYSE:LH) five years ago would have delivered you a 85% gain - simplywall.st
Predictive Oncology Inc. Develops Exclusive 3D Organoid Models for Labcorp to Enhance Drug Discovery and Safety Evaluation - Nasdaq
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp - Yahoo Finance
Labcorp Hldgs (LH) Price Target Raised by Morgan Stanley | LH St - GuruFocus
Kirby McInerney LLP Reminds Fortrea Holdings Inc. (FTRE) Investors of Class Action Filing and Encourages Investors to Contact the Firm - FinancialContent
Kaplan Fox Alerts Investors to a Securities Class Action Against Fortrea Holdings Inc. (FTRE)Deadline is August 1, 2025 - The Globe and Mail
Labcorp v. Davis Challenge Regarding Uninjured Class Members Dismissed as Improvidently Granted - Wilson Sonsini
What 8 Analyst Ratings Have To Say About Labcorp Hldgs - Benzinga
Just One Day Away – Register Now for HMG Strategy’s 9th Annual New York CISO & Technology Leadership Summit on June 12 - GlobeNewswire Inc.
Labcorp Hldgs (LH) Price Target Raised by Morgan Stanley | LH Stock News - GuruFocus
Analyst Boosts Price Target for Labcorp (LH) Amid Positive Growt - GuruFocus
Morgan Stanley Raises Price Target on Labcorp Holdings to $283 From $270 - marketscreener.com
LabCorp stock hits 52-week high at $258.7 amid robust growth By Investing.com - Investing.com South Africa
Justice Kavanaugh Signals One Conservative Vote in Labcorp Toward Imposing a Pre-Certification Standing Requirement Under FRCP 23 - The National Law Review
LabCorp stock hits 52-week high at $258.7 amid robust growth - Investing.com India
Labcorp Holdings Inc. Shares Soar 1.46% to 52-Week High on Strong Q1 Earnings - AInvest
FTRE INVESTOR ALERT: Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
The Supreme Court's dismissal of Labcorp v. Davis - Daily Journal
SCOTUS Declines to Decide Fate of Classes with Uninjured Members: 8-1 Decision in LabCorp Leaves Unresolved Whether Rule 23 Allows Certification for a Class Containing Members Who Lack Standing - The National Law Review
1.12%
자본화:
|
볼륨(24시간):